Correlation Between Mydecine Innovations and Khiron Life

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mydecine Innovations and Khiron Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mydecine Innovations and Khiron Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mydecine Innovations Group and Khiron Life Sciences, you can compare the effects of market volatilities on Mydecine Innovations and Khiron Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mydecine Innovations with a short position of Khiron Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mydecine Innovations and Khiron Life.

Diversification Opportunities for Mydecine Innovations and Khiron Life

-0.16
  Correlation Coefficient

Good diversification

The 3 months correlation between Mydecine and Khiron is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Mydecine Innovations Group and Khiron Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Khiron Life Sciences and Mydecine Innovations is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mydecine Innovations Group are associated (or correlated) with Khiron Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Khiron Life Sciences has no effect on the direction of Mydecine Innovations i.e., Mydecine Innovations and Khiron Life go up and down completely randomly.

Pair Corralation between Mydecine Innovations and Khiron Life

If you would invest  0.40  in Mydecine Innovations Group on October 23, 2024 and sell it today you would earn a total of  0.10  from holding Mydecine Innovations Group or generate 25.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy98.36%
ValuesDaily Returns

Mydecine Innovations Group  vs.  Khiron Life Sciences

 Performance 
       Timeline  
Mydecine Innovations 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Mydecine Innovations Group are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, Mydecine Innovations reported solid returns over the last few months and may actually be approaching a breakup point.
Khiron Life Sciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Khiron Life Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Khiron Life is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.

Mydecine Innovations and Khiron Life Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mydecine Innovations and Khiron Life

The main advantage of trading using opposite Mydecine Innovations and Khiron Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mydecine Innovations position performs unexpectedly, Khiron Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Khiron Life will offset losses from the drop in Khiron Life's long position.
The idea behind Mydecine Innovations Group and Khiron Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.